α-Lipoic acid supplementation inhibits oxidative damage, accelerating chronic wound healing in patients undergoing hyperbaric oxygen therapy

被引:46
作者
Alleva, R [1 ]
Nasole, E
Di Donato, F
Borghi, B
Neuzil, J
Tomasetti, M
机构
[1] IRCCS Ist Ortopedici Rizzoli, Dept Anesthesiol, Bologna, Italy
[2] Hyperbar Ctr MPM, Bologna, Italy
[3] Griffith Univ, Sch Med Sci, Apoptosis Res Grp, Southport, Qld, Australia
[4] Acad Sci Czech Republ, Inst Mol Genet, Lab Apoptosis & Cell Signalling, Prague, Czech Republic
[5] Polytech Univ Marche, Dept Mol Pathol & Innovat Therapies, Ancona, Italy
关键词
alpha-lipoic acid; chronic wound; ROS; DNA damage; lipid peroxidation; cytokines;
D O I
10.1016/j.bbrc.2005.05.119
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperbaric oxygen (HBO) therapy is successfully used for the treatment of a variety of conditions. However, prolonged exposure to high concentrations of oxygen induces production of reactive oxygen species, causing damage to the cells. Thus, antioxidant supplementation has been proposed as an adjuvant to attenuate such deleterious secondary effects. We evaluated the effects of alpha-lipoic acid (LA) in patients affected by chronic wounds undergoing HBO treatment. LA supplementation efficiently reduces both the lipid and DNA oxidation induced by oxygen exposure. LA exerted its antioxidant activity by directly interacting with free radicals or by recycling vitamin E. An inhibitory effect of LA on the pro-inflammatory cytokine interleukin-6 was observed. Taken together, we demonstrated an adjuvant effect of LA in HBO therapy used for impaired wound healing treatment. We propose that LA may be used to further promote the beneficial effects of HBO therapy. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:404 / 410
页数:7
相关论文
共 34 条
[1]  
Abidia H, 2001, BRIT J SURG, V88, P744
[2]   Proteinases, their inhibitors, and cytokine profiles in acute wound fluid [J].
Baker, EA ;
Leaper, DJ .
WOUND REPAIR AND REGENERATION, 2000, 8 (05) :392-398
[3]   Oxidative stress and antioxidant status in patients undergoing prolonged exposure to hyperbaric oxygen [J].
Benedetti, S ;
Lamorgese, A ;
Piersantelli, M ;
Pagliarani, S ;
Benvenuti, F ;
Canestrari, F .
CLINICAL BIOCHEMISTRY, 2004, 37 (04) :312-317
[4]   α-lipoic acid in liver metabolism and disease [J].
Bustamante, J ;
Lodge, JK ;
Marcocci, L ;
Tritschler, HJ ;
Packer, L ;
Rihn, BH .
FREE RADICAL BIOLOGY AND MEDICINE, 1998, 24 (06) :1023-1039
[5]   Is hyperbaric oxygen a useful adjunct in the management of problem lower extremity wounds? [J].
Ciaravino, ME ;
Friedell, ML ;
Kammerlocher, TC .
ANNALS OF VASCULAR SURGERY, 1996, 10 (06) :558-562
[6]   DIRECT ENZYMATIC DETECTION OF ENDOGENOUS OXIDATIVE BASE DAMAGE IN HUMAN LYMPHOCYTE DNA [J].
COLLINS, AR ;
DUTHIE, SJ ;
DOBSON, VL .
CARCINOGENESIS, 1993, 14 (09) :1733-1735
[7]   Analysis of oxidative DNA damage and HPRT mutations in humans after hyperbaric oxygen treatment [J].
Dennog, C ;
Gedik, C ;
Wood, S ;
Speit, G .
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 1999, 431 (02) :351-359
[8]  
Doctor N, 1992, J Postgrad Med, V38, P112
[9]   Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer - A randomized study [J].
Faglia, E ;
Favales, F ;
Aldeghi, A ;
Calia, P ;
Quarantiello, A ;
Oriani, G ;
Michael, M ;
Campagnoli, P ;
Morabito, A .
DIABETES CARE, 1996, 19 (12) :1338-1343
[10]   Determination of lipoic acid and dihydrolipoic acid in human plasma and urine by high-performance liquid chromatography with fluorimetric detection [J].
Haj-Yehia, AI ;
Assaf, P ;
Nassar, T ;
Katzhendler, J .
JOURNAL OF CHROMATOGRAPHY A, 2000, 870 (1-2) :381-388